We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Atosiban?

Mary McMahon
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Atosiban is a hormone doctors may prescribe to stop premature labor with the goal of keeping the baby inside the uterus as long as possible. This drug will stop or weaken uterine contractions. It is not available in all nations, and is one among a library of drugs doctors can use in the management of preterm labor. Patients who want to know more about how a doctor will manage premature labor in their case can discuss this while developing a birth plan to get an idea of the available options. Knowing what will happen ahead of time can make the experience less frightening.

This medication suppresses the activities of oxytocin and vasopressin, two hormones involved in stimulating uterine contractions. Women in premature labor will deliver their babies if the cervix is allowed to dilate and uterine contractions increase in frequency and intensity. Stopping those contractions can halt the labor. While the baby may still ultimately be delivered early, putting the brakes on labor with drugs like atosiban provides an opportunity for interventions like steroid injections to develop the baby's lungs, increasing the chances of survival outside the womb.

If a patient enters premature labor and a doctor feels atosiban is an appropriate treatment, a nurse or doctor can perform an intravenous injection or add the medication to an intravenous drip, adjusting the settings to deliver the medication within the desired time frame. The patient should report on the strength of contractions in the meanwhile so care providers can determine if the medication is working. Doctors may also listen to the fetal heart rate, checking for signs of fetal distress and other issues that might complicate the case.

Labor repressants like atosiban can be useful for slowing the onset of labor. In premature labor, the longer the baby stays inside, the better the chances at the time of delivery. In some cases, it may be possible to stop labor altogether, allowing the fetus to develop to full maturity and deliver on the due date. In other cases, the patient may go back into labor when the hormones wear off. A doctor can decide to administer another dose of drugs or move forward with delivering the baby and providing medical interventions to address issues like low birth weight and incomplete lung formation.

People with a history of premature labor may want to discuss this when developing a birth plan and meeting with an obstetrician. It is especially advisable to note any prior allergic or other bad reactions to drugs like atosiban. Being aware of bad drug reactions will allow a doctor to choose a more appropriate medication to use when treating premature labor.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a The Health Board researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.